Our Recommendations
- Recommendations on the delivery of health services for the prevention and care of sexually transmitted infections (2025)
- Outcomes of lenacapavir administration during pregnancy (2025)
- Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness (2025)
- Should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP? (2025)
- Systematic review of values and preferences for lenacapavir as pre-exposure prophylaxis and other forms of long-acting injectable PrEP (2025)
New Publications
- Recommendations on the delivery of health services for the prevention and care of sexually transmitted infections (2025)
- Outcomes of lenacapavir administration during pregnancy (2025)
- Lenacapavir-associated drug resistance: implications for scaling up long-acting PrEP (2025)
- Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness (2025)
- Should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP? (2025)
Filter
359
Featured
Recommendations
23
New Publications
43
Language
Document type
Guidelines
126
No document type
121
Studies & Reports
65
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Brochures
1
Online Courses
1
Countries / Regions
Malawi
8
Global
8
Latin America and the Carribbean
7
South Africa
7
Africa
5
East and Southern Africa
5
Uganda
4
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Kenya
2
Lesotho
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
USA
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Argentina
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
53
Countries
30
Women & Child Health
8
Pharmacy & Technologies
3
Public Health
2
Capacity Building
1
Key Resources
1
Technical Report
AIDS Medicines and diagnostics service
September 2016
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
Dispatches
DOI: http://dx.doi.org/10.3201/eid2203.151607
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 3, March 2016
• PrEP is highly effective in preventing the sexual transmission of HIV.
• For PrEP to work well, it’s important to take the pills regularly.
• While PrEP can prevent HIV, it does not protect against other sexually transmitted infections.
Session V: Regulatory & quality assurance aspects
Update on prequalification of ARVs and regional harmonisation of medicine registration
Deusdedit K. Mubangizi
Group Lead, Inspections, WHO-PQT E-mail: mubangizid@who.int
Acknowledgements:
• Matthias Stahl
• Milan Smid
• Antony Fake
...
Boniface Dongmo-Nguimfack WHO/HIV/SIP
08. March 2016
HIV testing
Policy Brief
July 2015
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
HIV testing
Policy Brief
July 2015
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
Pre-exposure prophylaxis (PrEP)
Policy Brief
November 2015
Second Edition
AIDS Medicines and diagnostics services
July 2015
Guidelines
HIV testing services
July 2015
Technical Report
AIDS Medicines and diagnostics service
July 2015
Technical Report
AIDS Medicines and diagnostics service
July 2015
